Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
214
Total Claims
$178K
Drug Cost
37
Beneficiaries
$4,798
Cost/Patient
Risk Score Breakdown 43/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+980%
Opioid rate vs peers
67.8% vs 6.3% avg
-65%
Cost per patient vs peers
$4,798 vs $14K avg
+34%
Brand preference vs peers
19.6% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 980% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
67.8%
Opioid Rate
145
Opioid Claims
$3,703
Opioid Cost
27.6%
Long-Acting Rate
This provider's opioid prescribing rate of 67.8% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 42 claims · $174K
Generic: 172 claims · $3,899
Patient Profile
44
Avg Age
68%
Female
5.47
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About